Nov 17, 2022 / 08:00PM GMT
Jacob K. Johnson - Stephens Inc., Research Division - MD & Analyst
All right. Good afternoon, everybody. Welcome to the final session of Nashville 2022. We're going to end with a good one. I'm Jacob Johnson, the life science tools and former services analyst here at Steven. Really pleased to be joined with the team from West this afternoon. We have the man of many hats, Quintin Lai, VP of Corporate Development, Strategy and Investor Relations; and then Chad Winters, VP and Controller. So fireside chat format. I'll run the Q&A but try to open it up to the audience here.
And with that out of the way, Quintin, I'll turn it over to you for any opening remarks, and then we'll launch into Q&A.
Quintin J. Lai - West Pharmaceutical Services, Inc. - VP of Strategy & IR
Well, thank you. And on behalf of West, Chad and I would like to thank you, Jacob, and your associates for hosting us here at this conference at really well-run conference, and we've had a very good day of meetings. So thank you again. So for those of you who may be not as familiar
West Pharmaceutical Services Inc at Stephens Investment Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers